PACS241115P50000
- 17.50
- 0.000.00%
PACS Group Newsroom
Pacs Group Resumed With an Overweight at JPMorgan
Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
PACS Group Plunges After Reporting Preliminary Results, Postponing Q3 Release
Unveiling 8 Analyst Insights On PACS Group
Exact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
J.P. Morgan Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $40
Market-Moving News for November 6th
Express News | Pacs Group Shares Down 21.8% After Co Postpones Q3 Results
PACS Group Analyst Ratings
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Express News | Pacs Group Inc : JP Morgan Resumes Coverage With Overweight Rating; Target Price $40
PACS Group Reveals Postponement Of Release Of Q3 Results; Says It Received Civil Investigative Demands From Federal Government Regarding Reimbursement And Referral Practices
PACS Group Expects to Have Ended 3Q With More Than $600M of Cash and Available Liquidity >PACS
PACS Group: Audit Committee, With Assistance From External Counsel, Is Conducting an Investigation of Third-Party Allegations >PACS
PACS Group Postpones 3Q 2024 Fincl Results Conference Call >PACS
Express News | Pacs Group Provides Preliminary Third Quarter Operational Metrics
PACS Group Provides Preliminary Third Quarter Operational Metrics
Truist Financial Issues a Buy Rating on PACS Group Inc (PACS)
Top 3 Health Care Stocks You'll Regret Missing In November